Consultation ARM 80 seeks your views on the reclassification of Clarityn Allergy 10 mg tablets (loratadine) 30 tablet pack size from Pharmacy (P) to General Sales List (GSL). The Reclassification Summary and patient information leaflet as provided by the applicant company are displayed below.
Comments should be sent either by post to Abiodun Aderogba in Area 3-M, 151 Buckingham Palace Road, London, SW1W 9SZ or by email (reclassification@mhra.gsi.gov.uk) to arrive by 9 February 2012. Contributions received after that date cannot be included in the exercise.
Please inform us of your email address if you wish to receive an electronic copy of all future consultations via email.
To help informed debate on the issues raised by this consultation exercise, and within the terms of the Freedom of Information Act, the Agency intends to make copies of comments received publicly available. Unless you state otherwise we will assume that you have no objections to your comments being publicly available on the Agency’s website.
Public consultation (ARM 80): Request to reclassify Clarityn Allergy 10 mg tablets (loratadine) 30 tablet pack size from Pharmacy (P) to General Sales List (GSL) 
